In 1994 was created Burrill & Company, which is appeared as VC. The venture was found in North America in United States. The leading representative office of defined VC is situated in the San Francisco.
Comparing to the other companies, this Burrill & Company performs on 3 percentage points less the average number of lead investments. The top activity for fund was in 2004. The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies. The fund is generally included in 2-6 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2014. When the investment is from Burrill & Company the average startup value is 50-100 millions dollars.
This organization was formed by G. Steven Burrill. We also calculated 5 valuable employees in our database.
The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Medical, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Catalyst Biosciences, diaDexus, Light Sciences Oncology. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Burrill & Company, startups are often financed by Khosla Ventures, DSM Venturing, Prolog Ventures. The meaningful sponsors for the fund in investment in the same round are Prolog Ventures, Great Spirit Ventures, Novo Holdings. In the next rounds fund is usually obtained by Novo Holdings, Morgenthaler Ventures, Prolog Ventures.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Nora Therapeutics | $18M | 17 Apr 2014 | Palo Alto, California, United States | ||
Neos Therapeutics | $15M | 04 Mar 2014 | Grand Prairie, Texas, United States | ||
BetterDoctor | $2M | 22 Oct 2013 | San Francisco, California, United States | ||
$48M | 29 May 2013 | Dubai, United Arab Emirates | |||
Strand Life Sciences | 14 Feb 2013 | Bengaluru, Karnataka, India | |||
MabVax Therapeutics | $5M | 20 Nov 2012 | San Diego, California, United States | ||
Waterstone Pharmaceuticals | $3M | 21 Aug 2012 | Jiang'an District, Hubei, China | ||
AliveCor | $10M | 10 Jun 2012 | Mountain View, California, United States | ||
AliveCor | $3M | 02 Aug 2011 | Mountain View, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Nora Therapeutics | $18M | 17 Apr 2014 | Palo Alto, California, United States | ||
Neos Therapeutics | $15M | 04 Mar 2014 | Grand Prairie, Texas, United States | ||
BetterDoctor | $2M | 22 Oct 2013 | San Francisco, California, United States | ||
$48M | 29 May 2013 | Dubai, United Arab Emirates | |||
Strand Life Sciences | 14 Feb 2013 | Bengaluru, Karnataka, India | |||
MabVax Therapeutics | $5M | 20 Nov 2012 | San Diego, California, United States | ||
Waterstone Pharmaceuticals | $3M | 21 Aug 2012 | Jiang'an District, Hubei, China | ||
AliveCor | $10M | 10 Jun 2012 | Mountain View, California, United States | ||
AliveCor | $3M | 02 Aug 2011 | Mountain View, California, United States |